Edward K. Sarfo

Icahn School of Medicine at Mount Sinai — United States

Immunology and Microbiology · Life Sciences

13h-index752citations24works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(13), vaccines and immunoinformatics approaches(6), Monoclonal and Polyclonal Antibodies Research(4), Innovations in Medical Education(3), Immunotherapy and Immune Responses(3)

Publications24 total

Validity and equity of the AAMC PREview situational judgment test in U.S. medical school admissions
Medical Teacher·2026
Validity and equity of the AAMC PREview situational judgment test in U.S. medical school admissions
Figshare·2026Open Access
Validity and equity of the AAMC PREview situational judgment test in U.S. medical school admissions
Figshare·2026Open Access
Barriers to Exclusive Breastfeeding Among Nursing Mothers at Tamale West Hospital: A Cross-Sectional Study
2025Open Access
Improved targeting and elicitation of VRC01-class precursors by an optimized glycan-masking mutant of OD-GT8
2025Open Access
Systemic and Mucosal Humoral Immune Responses to Lumazine Synthase 60-mer Nanoparticle SARS-CoV-2 Vaccines
Vaccines·2025· 1 citedOpen Access
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
Cell·2024· 22 citedOpen Access
Cholesterol reduction by immunization with a PCSK9 mimic
Cell Reports·2024· 3 citedOpen Access
Acute thrombocytosis in a patient treated with ertapenem
European Journal of Case Reports in Internal Medicine·2024· 4 citedOpen Access
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base
iScience·2024· 6 citedOpen Access
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability
Nature Communications·2024· 15 citedOpen Access
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization
Journal of Virology·2023· 16 citedOpen Access
Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
Vaccines·2022· 6 citedOpen Access
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
EClinicalMedicine·2022· 38 citedOpen Access
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Nature Medicine·2021· 158 citedOpen Access
Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats
Molecular Autism·2020· 42 citedOpen Access
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
Cell Reports·2020· 25 citedOpen Access
Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats
Research Square (Research Square)·2020Open Access
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses
Journal of Virology·2020· 33 citedOpen Access
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Scientific Reports·2020· 55 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

John R. Mascola(15), Peter D. Kwong(15), Angela R. Corrigan(12), Shuishu Wang(12), Li Ou(11), Baoshan Zhang(10), Tongqing Zhou(9), Sijy O’Dell(9), Yaroslav Tsybovsky(8), Kai Xu(8), Hui Geng(8), Reda Rawi(8), Nicole A. Doria‐Rose(8), Cheng Cheng(8), Xuejun Chen(7), Adrian B. McDermott(7), Richard A. Koup(7), Hongying Duan(7), Gwo‐Yu Chuang(7), Anita Changela(7)